Browse > Article

The Effect of $\gamma$-PGA on NC/Nga Mice, a Mouse Model for Mite Antigen-induced Atopic Dermatitis  

Jang, Soon-Nam (Department of Bioengineering, Graduate School at Konkuk University)
Kim, Kum-Lan (Department of Bioengineering, Graduate School at Konkuk University)
Yun, Mi-Young (Department of Beauty Health Care, Daejeon University)
Kang, Sang-Mo (Department of Bioengineering, Graduate School at Konkuk University)
Publication Information
Microbiology and Biotechnology Letters / v.38, no.1, 2010 , pp. 53-63 More about this Journal
Abstract
As one of the mucous components of Cheonggukjang, traditional fermented soybean paste, $\gamma$-PGA is a natural substance with diverse functions. In this paper, an in-vivo experiment has been performed using NC/Nga mice in order to find out the efficacy of $\gamma$-PGA in human atopic dermatitis. The NC/Nga mice with BMAC-induced atopic dermatitis were administered $\gamma$-PGA (PGA-HM) with 300 kDa and low-molecular $\gamma$-PGA (PGA-LM), respectively. As a result, a significant decrease in clinical skin severity score was detected in the group that was administered PGA-LM. In terms of serum IgE levels, a significant decline was observed in PGA-LM, compared to the control group. The serum IgG1 levels also decreased more in PGA-LM than in the control group. However, no significant difference was observed in both groups. To witness the induction of $CD4^+CD25^+foxp3^+$ Treg cells, mRNA was sampled from the back of PGA-HM- and PGA-LM-administered NC/Nga mice with atopic dermatitis. In terms of the production amount of foxp3 mRNA, which was measured in real-time PCR, the group that was administered PGA-LM was twice as high as the control group. According to a biopsy on the skin on the backs of the mice, the experimental group was also far lower than the control group in terms of epidermis thickness, mast cell infiltration and the number of $CCR3^+$ cells. Therefore, it has been confirmed that the atopic dermatitis symptoms decreased more in the PGA-LM-administered NC/Nga mice than the PGA-HM-administered group by facilitating $CD4^+CD25^+foxp3^+$ Treg cells and suppressing the activity of eosinophils and production of IgE and pro-inflammatory cytokines.
Keywords
$\gamma$-PGA; $CD4^+CD25^+foxp3^+$ (Treg); BMAC; NC/Nga;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By SCOPUS : 0
연도 인용수 순위
1 Brunkow, M. E., E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 27: 68-73.
2 Clipstone, N. A. and G. R. Crabtree. 1992. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357: 695-697.   DOI   ScienceOn
3 Dieckmann, D., C. H. Bruett, H. Ploettner, M. B. Lutz, and G. Schuler. 2002. Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. J. Exp. Med. 196: 247-253.   DOI   ScienceOn
4 Gutermuth, J., M. Ollert, J. Ring, H. Behrendt, and T. Jakob. 2004. Mouse models of atopic eczema critically evaluated. Int. Arch. Allergy Immunol. 135: 262-276.   DOI   ScienceOn
5 Liu, J., J. D. Farmer, W. S. Jr., Lane, J. Friedman, I. Weissman, and S. L. Schreiber. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807-815.   DOI   ScienceOn
6 Nakamura, K., A. Kitani, and W. Strober. 2001. Cell contactdependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194: 629-644.   DOI   ScienceOn
7 Obst, M. and A. Steinbuchel. 2004. Microbial Degradation of Poly(amino acid)s. Biomacromolecules 5: 1166-1176.   DOI   ScienceOn
8 Perez-Camero, G., F. Congregado, J. J. Bou, and S. Munoz- Guerra. 1999. Biosynthesis and ultrasonic degradation of bacterial poly(gamma-glutamic acid). Biotechnol. Bioeng. 63: 110-115.   DOI   ScienceOn
9 Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant TH2-like bronchoalveolar Tlymphocyte population in atopic asthma. N. Engl. J. Med. 326: 298-304.   DOI   ScienceOn
10 Rousset, F., J. Robert, M. Andary, J. P. Bonnin, G. Souillet, I. Chretien, F. Briere, J. Pene, and J. E. de Vries. 1991. Shifts in interleukin-4 and interferon-gamma production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J. Allergy Clin. Immunol. 87: 58-69.   DOI
11 Shih, I. L. and Y. T. Van. 2001. The production of poly- (gamma-glutamic acid) from microorganisms and its various applications. Bioresour. Technol. 79: 207-225.   DOI   ScienceOn
12 Takano, N., I. Arai, and M. Kurachi. 2006. A method to induce stable atopic dermatitis-like symptoms in NC/Nga mice housed with skin-lesioned mice. Br. J. Dermatol. 154: 426-430.   DOI   ScienceOn
13 Vanderlugt, C. L. and S. D. Miller. 2002. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2: 85-95.   DOI   ScienceOn
14 Chernajovsky, Y., D. J. Gould, and O. L. Podhajcer. 2004. Gene therapy for autoimmune diseases: quo vadis? Nat Rev Immunol. 4: 800-811.   DOI   ScienceOn
15 Hashimoto, Y., I. Arai, Y. Nakanishi, T. Sakurai, A. Nakamura, and S. Nakaike. 2004. Scratching of their skin by NC/Nga mice leads to development of dermatitis. Life Sci. 76: 783-794.   DOI   ScienceOn
16 Leung, D. Y. 2000. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J. Allergy Clin. Immunol. 105: 860-876.   DOI   ScienceOn
17 Sasakawa, T., Y. Higashi, S. Sakuma, Y. Hirayama, Y. Sasakawa, Y. Ohkubo, and S. Mutoh. 2004. Topical application ofFK506 (tacrolimus) ointment inhibits mite antigeninduced dermatitis by local action in NC/Nga mice. Int. Arch. Allergy Immunol. 133: 55-63.   DOI   ScienceOn
18 Taniguchi, Y., K. Kohno, S. Inoue, S. Koya-Miyata, I. Okamoto, N. Arai, K. Iwaki, M. Ikeda, and M. Kurimoto. 2003. Oral administration of royal jelly inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice. Int. Immunopharmacol. 3: 1313-1324.   DOI   ScienceOn
19 O'Keefe, S. J., J. Tamura, R. L. Kincaid, M. J. Tocci, and E. A. O'Neill. 1992. FK-506 and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 357: 692-694.   DOI   ScienceOn
20 Gonzalez-Rey, E., A. Chorny, and M. Delgado. 2007. Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat. Rev. Immunol. 7: 52-63.   DOI   ScienceOn
21 Vestergaard, C., H. Yoneyama, and K. Matsushima. 2000. The NC/Nga mouse: a model for atopic dermatitis. Mol. Med. Today 6: 209-210.   DOI   ScienceOn
22 Miyamoto, K., S. Miyake, and T. Yamamura. 2001. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413: 531-534.   DOI   ScienceOn
23 Matsuda, H., N. Watanabe, G. P. Geba, J. Sperl, M. Tsudzuki, J. Hiroi, M. Matsumoto, H. Ushio, S. Saito, P. W. Askenase, and C. Ra. 1997. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol. 9: 461-466.   DOI
24 Vestergaard, C., H. Yoneyama, M. Murai, K. Nakamura, K. Tamaki, Y. Terashima, T. Imai, O. Yoshie, T. Irimura, H. Mizutani, and K. Matsushima. 1999. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J. Clin. Invest. 104: 1097-1105.   DOI   ScienceOn
25 Kotani, M., M. Matsumoto, A. Fujita, S. Higa, W. Wang, M. Suemura, T. Kishimoto, and T. Tanaka. 2000. Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice. J. Allergy Clin. Immunol. 106: 159-166.   DOI   ScienceOn
26 Van der Kleij, H. P., A. D. Kraneveld, A. H. van Houwelingen, M. Kool, A. C. Weitenberg, F. A. Redegeld, and F. P. Nijkamp. 2004. Murine model for non-IgEmediated asthma. Inflammation 28: 115-125.
27 Dogru, M., C. Katakami, N. Nakagawa, K. Tetsumoto, and M. Yamamoto. 1998. Impression cytology in atopic dermatitis. Ophthalmology 105: 1478-1484.   DOI   ScienceOn
28 Xavier, R. J. and D. K. Podolsky. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434.   DOI   ScienceOn
29 Aversa, G., J. Punnonen, B. G. Cocks, R. de Waal Malefyt, F. Vega, S. M. Jr., Zurawski, G. Zurawski, and J. E. de Vries. 1993. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J. Exp. Med. 178: 2213-2218.   DOI   ScienceOn
30 Hahm, J. H., T. Y. Lee, J. S. Lee, C. Park, M. H. Sung, and H. Poo. 2004. Antitumor effect of Poly-γ-glutamic acid by modulating cytokine production and NK cell activity. International Meeting of the Federation of Korean Microbiological Societies, p. 21-22.
31 Wang, G., T. Savinko, H. Wolff, M. C. Dieu-Nosjean, L. Kemeny, B. Homey, A. I. Lauerma, and H. Alenius. 2007. Repeated epicutaneous exposures to ovalbumin progressively induce atopic dermatitis-like skin lesions in mice. Clin. Exp. Allergy 37: 151-161.   DOI   ScienceOn
32 Lee, J. S., H. Poo, C. J. Kim, Y. H. Choi, C. Park, T. Y. Lee. and M. H. Sung. 2004. Effect of poly-gamma-glutamic acid as an adjuvant and immune response stimulatory factor in vitro and in vivo. The 16th Annual Meeting of the Korean Society for Molecular and Cellular Biology, pp. 14-15.
33 Kuhn, J. and S. Binder. 2002. RT-PCR analysis of 5' to 3'- end-ligated mRNAs identifies the extremities of cox2 transcripts in pea mitochondria. Nucleic Acids Res. 30: 439-446.   DOI
34 Bordi, F., C. Cametti, and G. Paradossi. 1996. A comparative study of the high-frequency dielectric properties of poly (alpha-glutamate) and poly (gamma-glutamate) aqueous solutions. Biopolymers 40: 485-494.   DOI   ScienceOn
35 Montagne, A., O. Grepinet, M. Peloille, F. Lantier, and A. C. Lalmanach. 2001. Quantification of ovine cytokine gene expression by a competitive RT-PCR method. J. Immunol. Methods. 253: 83-93.   DOI
36 Johrens, K., I. Anagnostopoulos, H. Durkop, and H. Stein. 2006. Different T-bet expression patterns characterize particular reactive lymphoid tissue lesions. Histopathology. 48: 343-352.   DOI   ScienceOn
37 Loser, K., W. Hansen, J. Apelt, S. Balkow, J. Buer, and S. Beissert. 2005. In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther. 12: 1294-1304.   DOI   ScienceOn
38 Selliah, N., W. H. Brooks, and T. L. Roszman. 1996. Proteolytic cleavage of alpha-actinin by calpain in T cells stimulated with anti-CD3 monoclonal antibody. J. Immunol. 156: 3215-3221.
39 Yawalkar, N., M. Uguccioni, J. Scharer, J. Braunwalder, S. Karlen, B. Dewald, L. R. Braathen, and M. Baggiolini. 1999. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J. Invest. Dermatol. 113: 43-48.   DOI   ScienceOn
40 Jang, S. N., K. L. Kim,, S. M. Kang. 2009. Effects of PGA-LM on CD4+/CD25+/foxp3+ Treg cell activation in isolated CD4+ T cells in NC/Nga mice. Kor. J. Microbiol. Biotechnol. 37: 160-169.
41 Sakaguchi, S. and F. Powrie. 2007. Emerging challenges in regulatory T cell function and biology. Science 317: 627-629.   DOI
42 Piccirillo, C. A., J. J. Letterio, A. M. Thornton, R. S. McHugh, M. Mamura, H. Mizuhara, and E. M. Shevach. 2002. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J. Exp. Med. 196: 237-246.   DOI   ScienceOn
43 Matsumoto, M., M. Kotani, A. Fujita, S. Higa, T. Kishimoto, M. Suemura, and T. Tanaka. 2002. Oral administration of persimmon leaf extract ameliorates skin symptoms and transepidermal water loss in atopic dermatitis model mice, NC/Nga. Br. J. Dermatol. 146: 221-227.   DOI   ScienceOn
44 Matsumoto, M., C. Ra, K. Kawamoto, H. Sato, A. Itakura, J. Sawada, H. Ushio, H. Suto, K. Mitsuishi, Y. Hikasa, and H. Matsuda. 1999. IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis. J. Immunol. 162: 1056-1063.
45 Kondo, E. and K. Yamada. 1957. End results of focal debridement in bone and joint tuberculosis and its indications. J. Bone Joint Surg. Am. 39-A: 27-31.
46 Tanaka, A., S. Muto, K. Jung, A. Itai, and H. Matsuda. 2007. Topical application with a new NF-kappaB inhibitor improves atopic dermatitis in NC/NgaTnd mice. J. Invest. Dermatol. 127: 855-863.   DOI   ScienceOn
47 Heinzmann, A. and A. Daser. 2002. Mouse models for the genetic dissection of atopy. Int Arch Allergy Immunol. 127: 170-180.   DOI   ScienceOn
48 Kidd, P. 2003. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 8: 223-246.
49 Barnes, P. J. 2008. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 8:183-192.   DOI   ScienceOn
50 Miyara, M. and S. Sakaguchi. 2007. Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 13: 108-116.   DOI   ScienceOn
51 Tone, Y., K. Furuuchi, Y. Kojima, M. L. Tykocinski, M. I. Greene, and M. Tone. 2008. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9: 194-202.   DOI   ScienceOn
52 Watanabe, A., H. Mishima, P. M. Renzi, L. J. Xu, Q. Hamid, and J. G. Martin. 1995. Transfer of allergic airway responses with antigen-primed CD4+ but not CD8+ T cells in brown Norway rats. J. Clin. Invest. 96: 1303-1310.   DOI   ScienceOn
53 Takakura, M., F. Takeshita, M. Aihara, K. Q. Xin, M. Ichino, K. Okuda, and Z. Ikezawa. 2005. Hyperproduction of IFNgamma by CpG oligodeoxynucleotide-induced exacerbation of atopic dermatitis-like skin lesion in some NC/Nga mice. J. Invest. Dermatol. 125: 1156-1162.   DOI   ScienceOn
54 Mastrandrea, F. 2004. The potential role of allergen-specific sublingual immunotherapy in atopic dermatitis. Am. J. Clin. Dermatol. 5: 281-294.   DOI   ScienceOn
55 Ferrick, D. A., M. D. Schrenzel, T. Mulvania, B. Hsieh, W. G. Ferlin, and H. Lepper. 1995. Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by gamma delta T cells in vivo. Nature 373: 255-257.   DOI